Results 201 to 210 of about 39,316 (219)

Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma

New England Journal of Medicine, 2015
Tadeusz Robak, Huiqiang Huang, Jun Zhu
exaly  

First-line bortezomib benefits patients with multiple myeloma

Nature Reviews Clinical Oncology, 2009
Evangelos Terpos
exaly  

A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

New England Journal of Medicine, 2003
Paul G Richardson, Sundar Jagannath, S Vincent Rajkumar   +2 more
exaly  

Bortezomib

Reactions Weekly, 2014
openaire   +1 more source

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma

New England Journal of Medicine, 2016
Antonio Palumbo, Katja C Weisel, Ajay K Nooka   +2 more
exaly  

A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib

Cancer Cell, 2005
Klaus Podar, Constantine Mitsiades, Hiroshi Yasui   +2 more
exaly  

Bortezomib

Reactions Weekly, 2017
openaire   +2 more sources

Bortezomib in newly diagnosed multiple myeloma

Nature Reviews Clinical Oncology, 2009
James R Berenson
exaly  

Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial

Lancet, The, 2017
Muneer H Abidi, S Vincent Rajkumar, Robert Z Orlowski   +2 more
exaly  

Bortezomib

Reactions Weekly, 2021
openaire   +1 more source